Mechanism
Sodium channels + GABA-A receptors
Assets acting on this target.
- Class
- Sodium channel antagonist and GABA-A receptor positive allosteric modulator
- Notes
- audit finding #412 (minor); source: https://api.fda.gov/drug/label.json?search=openfda.brand_name:Xcopri&limit=1